Zobrazeno 1 - 10
of 19
pro vyhledávání: '"John Neumeyer"'
Autor:
Louise, Lincoln, Ria, Fisher, Michael J, Jackson, Peter, Jenner, John, Neumeyer, Anna W, Sromek, Andrew J, Lees, Sarah, Rose
Publikováno v:
Movement disorders : official journal of the Movement Disorder Society. 31(9)
The D1/D2 dopamine agonist apomorphine has poor oral bioavailability, necessitating subcutaneous administration in the treatment of Parkinson's disease (PD). Acute subcutaneous injection is used as rescue therapy from "off" periods, whereas continuou
Autor:
Kazumata K, Dhawan V, Chaly T, Antonini A, Margouleff C, Belakhlef A, John Neumeyer, Eidelberg D
Publikováno v:
Scopus-Elsevier
Europe PubMed Central
Europe PubMed Central
Fluorinated N-3-fluoropropyl-2-beta-carboxymethoxy-3-beta-(4-iodophenyl) nortropane (FPCIT) has been synthesized as a dopamine transporter ligand for PET studies. We evaluated the regional brain uptake and the plasma metabolism of [18F]-FPCIT.PET stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::5379f0f124d41a2fff0570367a01701c
http://hdl.handle.net/11577/3252213
http://hdl.handle.net/11577/3252213
Autor:
Ishikawa T, Dhawan V, Kazumata K, Chaly T, Mandel F, John Neumeyer, Margouleff C, Babchyck B, Zanzi I, Eidelberg D
Publikováno v:
Europe PubMed Central
SPECT imaging of the dopamine transporter is now an alternative to PET in the quantification of nigrostriatal dopaminergic function. We compared [123I] beta CIT-FP/SPECT and [18F]FDOPA/PET in the assessment of nigrostriatal dopaminergic function in P
Publikováno v:
Europe PubMed Central
Iodine-123-beta-CIT is a SPECT radioligand for dopamine and 5-HT transporters with potential use in Parkinson's disease, schizophrenia and cocaine addiction studies. At present, preparation of no-carrier-added (NCA) [123I] beta-CIT is achieved by iod
Autor:
Jp, Seibyl, Wallace E, Eo, Smith, Stabin M, Rm, Baldwin, Zoghbi S, Zea-Ponce Y, Gao Y, Wy, Zhang, John Neumeyer
Publikováno v:
Europe PubMed Central
SPECT imaging with 123I-labeled methyl 3 beta-(4-iodophenyl)tropane-2 beta-carboxylate ([123I]beta-CIT) in nonhuman primates has shown brain striatal activity, which primarily reflects binding to the dopamine transporter. The biodistribution and calc
Publikováno v:
Europe PubMed Central
Alkyl and arylalkyl derivatives of the dopamine (DA) D2 antagonist spiperone were prepared and characterized chemically and pharmacologically. They included the N-methyl, N-phenethyl (NPS), and N-p-aminophenethyl (NAPS) derivatives, as well as the al
Autor:
Ao Zhang, John Neumeyer
Publikováno v:
Current Topics in Medicinal Chemistry. 7:341-341
Publikováno v:
Neurochemical Research; Oct2008, Vol. 33 Issue 10, p2142-2150, 9p
Publikováno v:
Europe PubMed Central
Prompted by conflicting reports of both agonist and antagonist properties of the S-(+)-enantiomer of the potent dopamine agonist R-(-)-N-n-propylnorapomorphine (NPA), we carried out extracellular, single unit recording studies to compare the effects
Publikováno v:
Europe PubMed Central
The potent cocaine analog 2 beta-carbomethoxy-3 beta-(4-fluorophenyl)-tropane (CFT, also designated WIN 35,428) was tritiated and evaluated as a molecular probe for cocaine receptors in caudate putamen membranes of cynomolgus monkeys. Kinetic, satura